A cardiovascular leader joins Editas as a director steps down
Editas Medicine has appointed Dr. Patrick T. Ellinor, a renowned leader in cardiovascular medicine and human genetics, to its Board of Directors, effective August 6, 2026. Dr. Ellinor's expertise is expected to significantly contribute to the advancement of EDIT-401 for hyperlipidemia and the company's …